Ozgene story

to advance humanity - inspire curiosity

It was not that long ago that a mouse was just a mouse. For the team at Ozgene, a mouse represents a way to advance humanity. Ozgene has become a company dedicated to exactly that, and we do it by inspiring curiosity within ourselves and our customers.

Ozgene was founded in November 1999 in Perth, Australia. Today, Ozgene is one of the leading companies providing genetically customised mice for researchers around the world. In fact, 90% of our customers are located outside of Australia and another Ozgene laboratory and breeding facility was launched in the US in 2019. Shipments leave the Ozgene facilities almost daily for their destinations in the US, Europe, Asia, South America and New Zealand. Ozgene mice can be found in laboratories on almost every continent in small academic institutions to multinational pharmaceutical companies. They have been for over 20 years. The experience behind Ozgene doesn’t stop there.

CEO and Co-founder, Dr Frank Koentgen, and the Ozgene team have 30 years of experience in the generation of genetically modified mice. It begins even before Ozgene was founded when Dr Koentgen generated the first knockout mouse on the C57BL/6 mouse strain background in 1993. Ozgene has since patented it's sequential cloning system and most recently the goGermline™ technology, which has been a game changer for gene targeting with numerous animal ethics, efficiency, and timeline benefits . During the COVID-19 pandemic, Ozgene has also provided organisational capability support and training to the CTMH Doctors Hospital to set up a COVID-19 testing facility in the Cayman Islands.